Immortalization of human oral keratinocytes is associated with elevation of telomerase activity and shortening of telomere length

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 799-804

  Guo, Wentong ^a   Kang, Mo K ^a   Kim, Hyun Jung ^a   Park, No Hee ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Human papilloma virus; Immortalization; Keratinocytes; Telomerase; Telomere

Indexed keywords

RIBONUCLEOPROTEIN; TELOMERASE; VIRUS DNA;

ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH MUCOSA; PRIORITY JOURNAL; TELOMERE; WART VIRUS;

EID: 0031864342     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.799     Document Type: Article

References (42)

1. Allshire RC, Dempster M and Hastie ND: Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 17: 4611-4627, 1989.
2. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Chang JF, Smith CL and Cantor CR: Isolation and characterization of a human telomere. Nucleic Acids Res 17: 6109-6127, 1989.
4. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW and Harley CB: Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220: 194-200, 1995.
5. Harley CB, Futcher AB and Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 345: 458-460, 1990.
6. Greider CW: Telomere length regulation. Annu Rev Biochem 65: 337-365, 1996.
7. Yegorov YE, Chernov DN, Akimov SS, Bolsheva NL, Krayevsky AA and Zelenin AV: Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblasts. FEES Lett 389: 115-118, 1996.
8. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997.
9. Greider CW and Blackburn EH: The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 51: 887-898, 1987.
10. Greider CW and Blackburn EH: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337: 331-337, 1989.
11. Harle-Bachor C and Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481, 1996.
12. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
13. Kang MK, Guo W and Park N-H: Replicative senescence of normal human oral keratmocytes is associated with the loss of telomerase activity without shortening of telomeres. Cell Growth Differ 9: 85-95, 1998.
14. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM and Greider CW: Telomerase, cell immortality and cancer. Cold Spring Harb Symp Quant Biol 59: 307-315, 1994.
15. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
16. Counter CM, Avilion AA, Le Feuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.
17. Klingelhutz AJ, Barber SA, Smith PP, Dyer K and McDougall JK: Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol Cell Biol 14: 961-969, 1994.
18. Gollahon LS and Shay JW: Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12: 715-725, 1996.
19. Stoppler H, Hartmann D, Sherman L and Schlegel R: The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem 272: 13332-13337, 1997.
20. Greer RO, Eversole LR and Crosby LK: Detection of human papillomavirus-genomic DNA in oral epithelial dysplasias, oral smokeless tobacco-associated leukoplakias, and epithelial malignancies. J Oral Maxillofac Surg 48: 1201-1205, 1990.
21. Wen S, Tsuji T, Li X, Mizugaki Y, Hayatsu Y and Shinozaki F: Detection and analysis of human papillomavirus 16 and 18 homologous DNA sequences in oral lesions. Anticancer Res 17: 307-312, 1997.
22. Paz IB, Cook N, Odom-Maryon T, Xie Y and Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79: 595-604, 1997.
23. Park NH, Min BM, Li SL, Huang MZ, Cherrick HM and Doniger J: Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 12: 1627-1631, 1991.
24. Shin K-H, Min B-M, Cherrick HM and Park N-H: Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog 9: 76-86, 1994.
25. Shay JW, Wright WE and Werbin H: Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1072: 1-7, 1991.
26. Klingelhutz AJ, Foster SA and McDougall JK: Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79-82, 1996.
27. Chang E and Harley CB: Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190-11194, 1995.
28. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK and Allshire RC: Telomere reduction in human colorectal carcinoma and with aging. Nature 346: 866-868, 1990.
29. Steenbergen RDM, Walboomers JMM, Meijer CJLM, van der Raaij-Helmer EMH, Parker JN, Chow LT, Broker TR and Snijders PJF: Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13: 1249-1257, 1996.
30. Counter CM, Gupta J, Harley CB, Leber B and Bacchetti S: Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85: 2315-2320, 1995.
31. Shay JW and Wright WE: Telomerase activity in human cancer. Curr Opin Oncol 8: 66-71, 1996.
32. Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M and Kubota Y: Telomerase activity in primary prostate cancer. J Urol 157: 1161-1165, 1997.
33. Brien TP, Kallakury BV, Lowry CV, Ambros RA, Muraca PJ, Malfetano JH and Ross IS: Telomerase activity in benign endometrium and endomethal carcinoma. Cancer Res 57: 2760-2764, 1997.
34. Anderson S, Shera K, Ihle J, Billman L, Goff B, Greer B, Tamimi H, McDougall J and Klingelhutz A: Telomerase activation in cervical cancer. Am J Pathol 151: 25-31, 1997.
35. Ahn MJ, Noh YH, Lee YS, Lee JH, Chung TJ, Kim IS, Choi IY, Kim SH, Lee JS and Lee KH: Telomerase activity and its clinicopathological significance in gastric cancer. Eur J Cancer 33: 1309-1313, 1997.
36. Kageyama Y, Kamata S, Yonese J and Oshima H: Telomere length and telomerase activity in bladder and prostate cancer cell lines. Int J Urol 4: 407-410, 1997.
37. Murakami J, Nagai N, Ohama K, Tahara H and Ide T: Telomerase activity in ovarian tumors. Cancer 80: 1085-1092, 1997.
38. Strahl C and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 16: 53-65, 1996.
39. Blasco MA, Lee H-W, Hande MP, Samper E and Lansdorp PM: Telomere shortening and tumor formation by mouse cells lacking telomerase. Cell 91: 25-34, 1997.
40. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P and De Lange T: A human telomeric protein. Science 270: 1663-1667, 1995.
41. Bianchi A, Smith S, Chong L, Elias P and De Lange T: TRF1 is a dimer and bends telomeric DNA. EMBO J 16: 1785-1794, 1997.
42. Van Steensel B and De Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 385: 740-743, 1997.